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RESUMO 
 
O objetivo deste estudo foi investigar a eficácia antimicrobiana de duas terapias 
alternativas contra Streptococcus mutans. Para isso, foram utilizados os tratamentos 
experimentais com plasma não térmico à pressão atmosférica (NTAP) com argônio e a 
inativação fotodinâmica (PDI) mediada por curcumina e EDTA, ativados com uma fonte de luz 
LED azul (385 – 515 nm). Para a avaliação do NTAP, discos de resina (7 mm de diâmetro e 0.8 
mm de espessura) foram confeccionados, polimerizados, polidos e esterilizados. Biofilme da 
cepa bioluminescente de S. mutans (JM10) foi cultivado sobre os discos de resina usando meio 
THY (0.65x) com 0.1% de sacarose em condições de microaerofilia (37°C, 24 h). Os discos 
foram divididos em 7 grupos: controle de crescimento (CON), clorexidina (CHX), argônio por 
150 s (ARG), tratamento com NTAP por 30 s (P30), por 90 s (P90), por 120 s (P120) e NTAP por 
150 s (P150). O NTAP foi aplicado usando um dispositivo de jato de plasma. Os biofilmes foram 
analisados através da contagem de unidades formadoras de colônias (CFU), ensaio de 
bioluminescência (BL), microscopia eletrônica de varredura (SEM) e reação em cadeia da 
polimerase (PCR). Para a avaliação da PDI, a atividade antibacteriana da curcumina e EDTA foi 
avaliada pela concentração inibitória mínima (MIC) e concentração bactericida mínima (MBC). 
O efeito sinérgico da combinação curcumina/EDTA foi investigado pelo índice de 
concentração inibitória fracionado (FICI). Culturas planctonicas de S. mutans (UA159) 
incubadas a 37°C por 18 h em condições de microaerofilia foram uilizadas para avaliar o efeito 
da combinação de 0,4% EDTA e curcumina (50 µM e 500 µM) com e sem fotoativação com luz 
azul. Clorexidina (0,2%) foi utilizada como controle positivo. As suspensões planctônicas foram 
analisadas através de CFU, microscopia confocal (CLSM), microscopia eletrônica de 
transmissão (TEM) e PCR. Os biofilmes tratados com NTAP mostraram uma redução 
significativa das CFU quando comparados com os grupos CON e ARG. Os valores de BL 
indicaram que os tratamentos com nos grupos P90, P120 e P150 reduziram significativamente 
a atividade metabólica do S. mutans quando comparados com CON, ARG e P30. O grupo CHX 
apresentou as menores médias de CFU e BL. A análise de SEM apresentou mudanças 
morfológicas significativas no biofilme tratado com NTAP. A PCR indicou danos à estrutura do 
DNA após o tratamento com NTAP. Curcumina e EDTA apresentaram valores MIC de 5 mM e 
0,125%, respectivamente. A combinação curcumina/EDTA resultou em uma interação 
antibacteriana sinérgica. Todas as combinações com curcumina e luz azul resultaram em uma 
  
completa inativação do S. mutans. As imagens de CLSM confirmaram esses resultados e as 
imagens de TEM mostraram alterações morfológicas significativas. Entretanto, não foram 
detectados danos na estrutura do DNA por PCR. Conclui-se que os tratamentos com NTAP e 
PDI mediada por curcumina/EDTA foram eficazes na inativação de S. mutans. 
 
Palavras-chave: Gases de Plasma, Inativação fotodinâmica, Curcumina, Desinfecção, Agentes 
fotossensibilizadores, Streptococcus mutans, Espécies reativas de oxigênio, Medições 
luminescentes. 
 
  
  
ABSTRACT 
 
The purpose of this study was to evaluate the efficiency of two alternative therapies 
for disinfection of Streptococcus mutans. The experimental treatments were Non-Thermal 
Atmospheric Plasma (NTAP) and curcumin and EDTA mediated Photodynamic Inactivation 
using a blue LED light source. For NTAP, composite discs (7 mm diameter, 0.8 mm thick) were 
fabricated and sterilized, and a biofilm from a bioluminescent S. mutans strain (JM10) was 
allowed to grow on the surface of the discs using THY medium (0.65x) supplemented with 
0.1% sucrose in microaerophilic condition (37°C, 24h). Discs were separated in 7 groups 
according to the applied treatment: Growth control (CON), Chlorhexidine (2% - CHX), Argon 
for 150 s (ARG), treatment with NTAP for 30 s (P30), 90 s (P90), 120 s (P120) and 150 s (P150) 
using a plasma jet device. Biofilms were analyzed by colony forming units (CFU), 
bioluminescence assay (BL), scanning electronic microscopy (SEM) and polymerase chain 
reaction (PCR). For PDI evaluation, antibacterial activity of curcumin with EDTA was evaluated 
by minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC). The 
synergic effect of the curcumin/EDTA mixture was confirmed by inhibitory fraction 
concentration index (FICI). Cultures of S. mutans (UA159) were incubated at 37°C for 18 h in 
microaerophilic conditions to evaluate the effect of the combination of 0,4% EDTA with 50 
µM and 500 µM curcumin, with and without exposure to blue light. The positive control group 
was 0,2% chlorhexidine. Planktonic suspensions were analyzed by CFU, confocal laser 
scanning microscopy (CLSM), transmission electronic microscopy (TEM) and PCR. The results 
showed that NTAP treated biofilms had a significant reduction in CFU compared to ARG and 
CON groups. The BL results indicated that NTAP treatment significantly reduced the metabolic 
activity for P90, P120 and P150, compared to CON, ARG and P30. However, the lowest mean 
CFU and BLA were observed for CHX. Significant morphological alterations were observed with 
SEM in the NTAP treated biofilm. Analysis with PCR indicated damage to the DNA structure 
after NTAP treatment. Curcumin with EDTA had MIC values of 5 mM and 0,125% respectively, 
while the combination of both resulted in synergic antibacterial interaction. All the blue light 
activated curcumin combinations resulted in complete inactivation of S. mutans. Results were 
confirmed by CLSM while TEM demonstrated significant morphological alterations. 
Nonetheless, no damage to DNA structure was detected by PCR. Treatment with NTAP and 
curcumin/EDTA mediated PDI were efficient to inactivate S. mutans. 
  
 
Keywords: Plasma gases, Photodynamic inactivation, Curcumin, Disinfection, Photosensitizing 
agents, Streptococcus mutans, Reactive oxygen species, Bioluminescent assays. 
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1. INTRODUÇÃO 
 
 
Estima-se que mais de 700 espécies bacterianas podem ser identificadas na 
cavidade bucal (Paster et al., 2001), sendo estes microrganismos os principais responsáveis 
pela maioria dos processos patológicos, como a cárie dental, doenças periodontal, 
endodôntica e periapical (Arora, 2013). As bactérias podem aderir a componentes específicos 
das células e tecidos do hospedeiro ou em outros microrganismos, levando ao 
desenvolvimento de biofilmes (Arora, 2013; Li et al., 2015).  
Os biofilmes são comunidades biológicas com um elevado grau de organização, 
onde as bactérias formam comunidades estruturadas, coordenadas e funcionais. Essas 
comunidades biológicas encontram-se embebidas em matrizes poliméricas produzidas pelas 
próprias bactérias (EPS), o que lhes permitem a sobrevivência mesmo em ambientes hostis 
(Yang et al., 2011; Sladek et al., 2007; Li et al., 2015). Os biofilmes são muito mais resistentes 
à fagocitose, anticorpos e antimicrobianos em comparação com as bactérias planctônicas (Li 
et al., 2015). 
O Streptococcus mutans tem sido referido como a principal espécie responsável 
pela cárie dental. Trata-se de um microrganismo gram-positivo, anaeróbio facultativo, que 
forma biofilmes nas estruturas dentais, infiltra em fissuras e pode desmineralizar o esmalte e 
a dentina com produção de ácidos. Nessas fissuras ele está bem protegido do oxigênio e da 
atividade antimicrobiana natural da saliva (Goree et al., 2006).  
O tratamento da cárie dental baseia-se em duas estratégias: (i) a remoção 
mecânica e (ii) a utilização de antissépticos (Delben et al., 2016). Mesmo associando a 
estratégia mecânica com a química, não se alcança a completa desinfecção e nestes casos, é 
necessária a utilização de agentes antibacterianos. Embora os agentes antibacterianos 
tenham se mostrado eficazes contra bactérias orais, vários efeitos adversos tem sido relatados 
como alteração nos valores de resistência de união (Comba et al., 2019; Nima et al., 2019), 
coloração marginal, microinfiltração e desenvolvimento de resistência bacteriana (Kampf, 
2016; Kim et al., 2018). Assim, é necessário buscar novas alternativas de tratamento, que 
permitam eliminar eficientemente os biofilmes orais sem provocar os problemas 
anteriormente mencionados. Nesse contexto, o desenvolvimento de novos métodos para 
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desinfeção de superfícies intraorais são de grande interesse para a Odontologia (Delben et al., 
2016).   
O plasma frio em pressão atmosférica, tem sido recentemente introduzido na área 
da Biomedicina. O plasma é considerado o quarto estado da matéria e pode ser definido como 
um gás parcialmente ionizado que se encontra em equilíbrio, e pode ser gerado 
artificialmente em laboratório a partir da ionização de gases. Tradicionalmente o plasma tem 
sido utilizado em várias áreas da indústria, como a eletrônica, energética, aeroespacial e 
ambiental (Yang et al., 2011; J.-H. Kim et al., 2014). O plasma frio pode ser gerado em pressão 
e temperatura ambiente com pouca energia, atuando física, química e biologicamente sobre 
tecidos vivos sem causar danos, possibilitando a sua utilização na medicina.  
Alguns tipos de plasma frio já são utilizados com fins médicos; entretanto, ainda é 
necessária a realização de novas pesquisas para sua aplicação em diferentes terapias (Fridman 
et al., 2008; Hoffmann et al., 2013; J.-H. Kim et al., 2014). Pesquisas têm mostrado que o 
plasma frio é capaz de desativar diferentes tipos de microrganismos, como bactérias, fungos 
e vírus (Sladek et al., 2007; Hong et al., 2009; Ermolaeva et al., 2011; Scholtz et al., 2015). 
Acredita-se que o ozônio e as espécies reativas de oxigênio (ROS) geradas pelo plasma, em 
contato com o meio ambiente que possam ocasionar dano ou morte bacteriana por meio da 
desidratação, lise da membrana celular e danos ao DNA, lipídios e proteínas (Sladek et al., 
2007; J. W. Lackmann & Bandow, 2014; Delben et al., 2016). Pouco se sabe sobre o efeito da 
NTAP no biofilme de S. mutans. A maioria de estudos nesta área, foram realizados com plasma 
não térmico gerado em uma câmara de vácuo ou do tipo descarga luminescente (Kelly-
Wintenberg et al., 1998; Hong et al., 2009). Estes sistemas são altamente eficientes, mas as 
condições em que foram desenvolvidos não se aplicam ao ambiente da cavidade bucal. O 
NTAP gerado em um dispositivo de jato de plasma pode alcançar locais inacessíveis por outros 
métodos e, portanto, devem ser estudados (Delben et al., 2016). 
A terapia fotodinâmica (PDT) baseia-se na aplicação tópica ou sistêmica de um 
agente fotossensibilizador não tóxico em um tecido. Em seguida, o tecido é irradiado com uma 
luz com comprimento de onda específico capaz de reagir com o fotossensibilizador. Neste 
momento, radicais livres são produzidos pela interação do fotossensibilizador com o oxigênio 
do meio ou pela transferência de energia para as moléculas de oxigênio. A produção de 
oxigênio singleto irá produzir alterações nas células doentes induzindo à morte celular (Nagata 
et al., 2012; Liu et al., 2015). Atualmente, a PDT vem sendo utilizada para o tratamento de 
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algumas doenças dermatológicas, alguns tipos de câncer e na oftalmologia (Kwiatkowski et 
al., 2018).  
A PDT também tem sido utilizada na inativação bacteriana com sucesso. Quando 
a PDT e utilizada para a inativação de bactérias e chamada inativação fotodinâmica (PDI).O 
uso desta terapia na Odontologia tem se mostrado efetivo na inativação de bactérias orais, 
associado ao uso de um fotossensibilizante azul e uma fonte de luz vermelha (Koshi et al., 
2011; Lee et al., 2012; Saitawee et al., 2018). Entretanto, novos fotossensibilizadores vêm 
sendo estudados, como por exemplo a curcumina. Este fotossensibilizador é um pigmento 
natural utilizado como saborizante extraído da Curcuma longa L., e tradicionalmente tem sido 
utilizado como antioxidante, anti-inflamatório e no tratamento de alguns tipos de câncer 
(Gunes et al., 2016; Tsuda, 2018). A curcumina absorve luz no comprimento de onda da luz 
azul (300 – 500 nm), o que é compatível com o comprimento de onda dos aparelhos 
fotoativadores utilizados na prática clínica odontológica (Cieplik et al., 2014; Leite et al., 2014; 
Saitawee et al., 2018). 
Com a finalidade de potencializar o efeito antibacteriano, alguns agentes 
desorganizadores da membrana bacteriana têm sido utilizados (Umerska et al., 2018). O ácido 
etilenodiamino tetra-acético (EDTA), por exemplo, é capaz de potencializar o efeito de alguns 
antibióticos e fotossensibilizadores. Além disso, ele pode alterar a permeabilidade da parede 
celular, facilitando o ingresso de diversas substâncias através da membrana celular (Hamoud 
et al., 2015, 2014). Entretanto, não existem dados sobre a sinergia entre curcumina e EDTA, 
nem dos efeitos na PDI mediado pela combinação de curcumina e EDTA contra S. mutans 
utilizando uma fonte de luz azul. 
Finalmente, estas duas terapias alternativas poderiam ser aplicadas na superfície 
dos tecidos dentais após a remoção de cáries ou após o preparo protético, com a finalidade 
de garantir uma maior descontaminação, reduzindo o risco de formação de lesões secundárias 
resultantes da presença das bactérias (Ritts et al., 2010; J.-H. Kim et al., 2014). Espera-se 
também que possam ser utilizadas na limpeza de fóssulas e fissuras previamente à aplicação 
de selantes, eliminando ou inativando o biofilme presente.  
Portanto, este trabalho teve como objetivo investigar a eficácia de duas terapias 
alternativas na desinfeção de superfícies contaminadas com S. mutans. No Capítulo 1 foram 
avaliados os efeitos do NTAP sobre o biofilme de S. mutans utilizando contagem de unidades 
formadoras de colônias (CFU), ensaio de bioluminescência, microscopia eletrônica de 
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varredura e reação em cadeia da polimerase (PCR). O Capítulo 2 avaliou a efetividade da PDI 
mediada pela combinação curcumina/EDTA, utilizando a concentração inibitória mínima, 
concentração bactericida mínima, índice de concentração inibitória fracionada, CFU, 
microscopia confocal, microscopia eletrônica de transmissão e PCR. 
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2. ARTIGOS 
2.1.  ARTIGO 1: Antibacterial efficacy of non-thermal atmospheric plasma against 
Streptococcus mutans biofilms  
Gabriel Nima, Erika Nikitza Harth-Chu, Beibei Lui, Rochelle Denise Hiers, David Wayne 
Dyer, Vanessa Pecorari, Sharukh Soli Khajotia, Fernando Luis Esteban Florez, Marcelo 
Giannini 
Abstract 
Objective: The aim of this study was to evaluate the antimicrobial efficacy of non-thermal 
atmospheric plasma (NTAP) against S. mutans biofilm.  
Methods: Resin discs (7mm diameter and 0.8mm thick) were fabricated, polymerized, wet-
polished, and UV sterilized. Discs were immersed in sterile water for monomer extraction 
(37°C, 24h). Biofilm of bioluminescent S. mutans strain (JM10) was grown on the resin discs 
using 0.65xTHY+0.1% sucrose medium in anaerobic conditions ((37°C, 24h). Discs were 
randomly divided into seven groups: control (CON), 2% chlorhexidine for 1 minute (CHX), 
argon gas 150s (ARG) and four NTAP treatments (30s, 90s, 120s, or 150s).  NTAP was applied 
using a plasma jet device. After treatment, cells were replenished using 1xTHY+1.0% glucose 
medium and incubated (37°C, 1h). Biofilms were analyzed through the counting of viable 
colonies (CFU), bioluminescence assay (BL), scanning electron microscopy (SEM), and 
polymerase chain reaction (PCR).  
Results: All NTAP-treated biofilm yielded a significant CFU reduction when compared to those 
of the ARG and CON. Values of BL indicated that NTAP treatment for 90s, 120s or 150s resulted 
in statistically significantly lower metabolic activity when compared to those of CON, ARG or 
NTAP for 30s groups. Biofilm treated with CHX displayed the lowest means of CFU and BL. SEM 
analysis showed significant morphological changes in NTAP-treated biofilm. PCR indicated 
damage to the DNA structure after NTAP treatment.  
Conclusion: NTAP treatment was effective in lowering the viability and metabolism of S. 
mutans in a time-dependent manner, suggesting its use as an intraoral surface-
decontamination strategy. 
Keywords: Non-thermal atmospheric plasma, Streptococcus mutans, Microbial inactivation, 
Bioluminescent assays, Composite resin, Reactive oxygen species. 
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1. Introduction 
The oral microbiome has been demonstrated to play a fundamental role in the 
maintenance of oral health [1] because it contributes for (I) humans’ genetic makeup, (II) 
induces angiogenesis and (III) helps develop the immune system of the host. [2, 3] Colombo 
et al. [1] while reviewing the microbiology of oral biofilm-dependent diseases (e.g., caries, 
gingivitis, periodontitis, etc.), [4] have indicated based on previous scientific evidence, [5] that 
oral biofilms can be classified as a sessile community of microorganisms irreversibly attached 
to a substratum (either biotic or abiotic) or to an interface. [4, 6, 7] In the biofilms, cells are 
embedded in a self-produced matrix of extracellular polymeric substances (EPS), [8] that not 
only act as a physical barrier to external aggressors (e.g., antibiotics, bacteriophages, host 
immune responses and mechanical forces), [9] but also permits efficient cooperation among 
cells (e.g., horizontal gene transfer, quorum sensing) [10] and the storage of nutrients. [11]  
In addition, depth-dependent changes in permeability, pH and oxygen 
concentrations allow for the establishment of micro-environments [12] that support a wide 
variety of commensal microorganisms (about 700 species) [13] while providing cells with an 
optimal environment for proliferation. [1,4–6] Other phenotypical changes reported include 
lower metabolic rates and higher resistance to antibiotics (4-250 fold, which corresponds 
around 1,000 times more) [14] when compared to their planktonic counterparts. [3,7] Even 
though Streptococcus mutans has been implicated as the major causative agent of primary 
and secondary caries, [15, 16] studies [17] have demonstrated that such microorganism 
accounts for less than 2% of the total caries-producing biomass in active carious lesions, 
thereby raising questions regarding its role as the primary cause of tooth decay. [18] According 
to Esteban Florez et al., [19] S. mutans has been used as a cariogenic model organism for many 
years due to its undisputable ability to metabolize sugars into acid, and because this 
microorganism is capable of forming biofilms through the deposition of water-insoluble 
glucans.  
The clinical management of dental caries involves the removal of disorganized and 
bacteria-contaminated hard tissues (e.g., enamel and dentin)_using high-speed diamond burs 
under abundant irrigation with air/water spray, followed by the placement of restorative 
dental biomaterials (either direct or indirect) [6]. However, despite the success and wide 
spread utilization of these invasive techniques, an excess of healthy tissues is typically 
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removed during this process. Such extensive tissue removal is made necessary to 
biomechanically prepare the tooth structure to receive and retain the restoration, reduce the 
bacterial load at the surgical site (cavity walls), and to maintain the long-term biological and 
mechanical integrity of the tooth structure. [20] Various antibacterial agents, such as 
chlorhexidine, sodium hypochlorite, and benzalkonium chloride have been used after the 
completion of cavity preparation procedures to control the viability of the bacterial load 
present. [21, 22] However, even though the antibacterial agents cited were shown to be 
effective against oral bacteria, several adverse effects have been reported on bond strength 
values, [23, 24] marginal staining, microleakage and development of bacterial resistance. [25, 
26]  
  In this critical scenario, the development of alternative approaches and 
techniques that are capable of effectively decontaminating non-shedding intraoral surfaces 
(either biotic or abiotic) without promoting the development of antibiotic resistance are of 
fundamental importance in modern dentistry. One possible alternative to overcome the 
limitations cited is the utilization of non-thermal atmospheric plasma (NTAP). Typically, NTAP 
is generated by the application of energy (either heat or a magnetic field) to an inert gas such 
as helium, argon or neon. The physical manifestation of such process is the promotion of 
electrons from the fundamental state into a higher energy state [27] with the subsequent 
formation of ions, electrons, protons, UV-radiation and reactive species of nitrogen and 
oxygen (RNS and ROS, respectively). [20, 28, 29] Due to its intrinsic properties, this room-
temperature and minimally invasive approach has been recently used in several industrial 
segments and health care-related fields including automobile, engineering, transport, 
electronics, food packing, cancer treatment, blood coagulation, cosmetic treatments, 
ophthalmology, urology and cardiology. [30-32] In dentistry, plasma has been used for surface 
decontamination, [20, 31, 33] to improve implant osseointegration, [34, 35] enhance the 
adhesion of polymeric materials to dentin, [36-38] improve the wettability of dental materials 
[39-41] and to enhance tooth whitening effects. [42-44] According to previous reports, [20, 
31, 33] the antibacterial properties [45] of the NTAP has been primarily correlated to NTAP’s 
ability to generate RNS and ROS. Delben et al. [28] while investigating the effect of NTAP 
against dual-species oral biofilms (Candida albicans and Staphylococcus aureus) have 
demonstrated using confocal and scanning electron microscopy analyses, that NTAP is 
effective in destroying and removing pathogenic biofilms. Other studies, [30, 46] have 
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indicated that NTAP is safe to be used on machined titanium surfaces, are not associated with 
the problems of traditional techniques (either mechanical or chemical, or a combination of 
both) and may reach sites that are not accessible to other methods. [28] The vast majority of 
studies available have investigated the utilization of vacuum chamber- or atmospheric glow 
discharge-generated low-pressure plasma. [47, 48] Even though these are highly efficient 
systems, they cannot be used intra-orally due to technological restrictions.  
Thus, the purpose of this study was to evaluate the antimicrobial efficacy of NTAP 
against intact biofilms of S. mutans. The null hypotheses tested were: (1) plasma is not 
antibacterial against intact biofilms of S. mutans, (2) plasma does not display time-dependent 
antibacterial effects, (3) plasma does not significantly alters the structure and morphology of  
S. mutans biofilms and (4) plasma is not capable of producing damage to the DNA of intact S. 
mutans biofilms. 
 
2. Materials and Methods 
2.1. Specimen fabrication 
Disc shaped specimens (diameter= 7.00 mm, thickness= 0.8 mm) were fabricated 
(single increment) using the microhybrid resin composite Point 4TM (shade A2, Kerr Corp., 
USA) and a custom-made metallic mold. Specimens were then light cured (40 s/specimen, 
from top) with visible light using an LED light-curing unit (Valo, Ultradent Products Inc.; South 
Jordan, UT, USA) before being sequentially finished and polished (180-1200 grit SiC, final 
polish= 0.5 µm, diamond aqueous suspension) under copious water irrigation in a semi-
automated grinder-polisher (MultiPrep TM, Allied High-Tech Products Inc., USA) following a 
previous protocol from our laboratory. [19] Polished specimens were then UV-sterilized in a 
crosslinker (254 nm, 800,000 mJ/cm2, CL-1000 UVP, LLC, USA) and stored in ultra-pure water 
for monomer extraction (37°C, 24 hours). 
 
2.2 Bacterial strain and growth conditions 
Experiments reported in the present study utilized a genetically modified and 
bioluminescent strain of S. mutans (JM10) constructed by Merritt et al., [49] that was 
validated [19] and recently optimized into a real-time high throughput methodology by 
Esteban Florez et al. [50] Detailed information regarding the process of JM10 construction 
have been reported previously [49]. In brief, S. mutans wild type (UA159) was modified by the 
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insertion of the firefly luc gene (luc) under the control of the S. mutans lactate dehydrogenase 
(ldh) promoter using a transport plasmid pJM-1 (Φ::(ldh-luc), SpcR). The successful 
construction of JM10 (luc-ldh) was then determined by its selection for antibiotic-resistant 
colonies on Todd-Hewitt agar plates (BD Difco, Franklin Lakes, NJ, USA) supplemented with 
0.3% yeast extract (EMD Millpore; Billerica, MA, USA) and spectinomycin (800 µg/mL; MP 
Biomedicals; Santa Ana, CA, USA). Colonies of JM10 were then cultivated under anaerobic 
conditions at 37°C for 48 hours.  
 
2.3 In vitro growth of biofilms 
Overnight cultures of JM10 were grown (18 h, 37ºC, static and anaerobically) in 
THY culture medium supplemented with 0.3% yeast extract (Y) and spectinomycin (32 µL) at 
oral temperature. Overnight cultures in THY with OD600 ≥ 0.900 (corresponding to 6.43 e+12 
CFU/mL) [50] were used as inoculum for biofilm grown. Biofilms were formed by mixing a 
1:500 dilution of an overnight culture in 0.65x THY medium supplemented with 0.1% (w/v) 
sucrose. Aliquots (2.5 mL/each) were individually dispensed into separate wells of sterile 12-
well plates (Falcon; Corning, NY, USA) containing the sterile and monomer-extracted 
specimens (as described in subsection 2.1.). Biofilms were then grown against the surfaces of 
specimens for 24 hours (static cultures, anaerobic conditions, 37°C). 
 
2.4 Plasma generation 
Non-thermal atmospheric plasma was generated using the hand-held unit 
(electromagnetic generator; power output: 45 W, frequency: ~30 kHz, Tension: 110 V) of a 
commercially available plasma-generating device (Surface Plasma Tool Model SAP; Surface–
Engineering and Plasma Solution; Campinas, SP, Brazil) from the ionization of argon gas (flow 
rate: 8 L/minute) at normal conditions of temperature and pressure. Detailed information 
regarding the plasma-generating device can be found in a previous publication. [51]  
 
2.5 Bioluminescence assay  
The present study utilized a real-time and high throughput bioluminescence assay 
(BL) recently optimized [50] to determine the metabolic status of intact S. mutans biofilms 
grown against the surfaces of relevant restorative dental biomaterials. The metabolic status 
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of S. mutans biofilms was determined at two distinct and subsequent time periods (baseline 
[BR] and after antibacterial treatments [AR]) to determine the antibacterial efficacy of 
treatments proposed (in terms of relative luminescence units [RLU]). Specimens fabricated for 
BL were subjected to the procedures described in subsections 2.1 and 2.3. After the biofilm 
growth period, specimens with 24-hour biofilms were individually and carefully transferred 
into separate wells of sterile 24-well plates containing 1 mL of 1x THY + 1% (w/v) glucose 
(recharge medium) and were incubated for 1 hour (at 37°C) to replenish their internal energy 
levels in preparation for the first round of high throughput bioluminescence testing (BR; prior 
to antibacterial treatment). The BR bioluminescence measurement was performed 
immediately after individually dispensing D-Luciferin aqueous solution (500 µL, 100 mM) 
suspended in 0.1 M citrate buffer (pH 6.0) into each well using a computer-controlled system 
in a Synergy HT Multi-mode microplate reader (Biotek, USA). The assessment of the temporal 
evolution of luciferase metabolic activity in intact biofilms of S. mutans was performed in 2-
min increments (6 min total; BR0-BR6) after the addition of D-Luciferin substrate at 530 nm. 
Afterwards, the media (1 mL of 1x THY + 1% (w/v) glucose + 500 µL of D-Luciferin) was carefully 
aspired from each well and 1 mL of 0.65x THY + 0.1% (w/v) sucrose was added (growth 
medium). Specimens were then randomly assigned into seven experimental groups, as 
described in Table 1 and, as follows: CON - Control (no treatment), CHX- Chlorhexidine 
gluconate 2%, ARG- Argon (150 s), P30- NTAP (30 s), P90- NTAP (90 s), P120 – NTAP (120 s) 
and P150- NTAP (150 s) before being subjected to experimental treatments proposed. The 
second round of bioluminescence assay (AR0-AR6) was performed under the same conditions 
and using the same procedures as previously described for BR.  
  
2.6 Antibacterial treatments  
Specimens were subjected to the conditions and antibacterial treatments 
described in Table 1. Specimens in CHX were exposed to 2% Chlorhexidine for 1 minutes 
following experimental protocols previously described. [19, 52] The rationale for the selection 
of Chlorhexidine as a positive control for the antibacterial effect, was based on the fact that 
Chlorhexidine has been shown to be an effective antibacterial agent against biofilms of S. 
mutans. [53, 54] Specimens in groups the other groups were subjected to experimental 
antibacterial treatments with argon (ARG) or plasma [plasma diameter= 2.00 mm; treatment 
times= 30 s (P30), 90 s (P90), 120 s (P120) and 150 s (P150), respectively] generated by the 
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hand-held unit (fixed height from specimens= 10.00 mm) of the plasma-generating device as 
described previously in subsection 2.4. During the treatment of each specimen, a single and 
previously calibrated operator, moved in a sweeping motion the petri dish (over a fixed 
surface) containing a single specimen to completely treat the surface of each specimen.   
 
2.7 Viable colony counts 
An additional set of specimens (n = 7/group; total of 28) were fabricated, wet-
polished, UV-sterilized and stored in sterile ultra-pure water according to procedures 
described in subsection 2.1. After that, specimens were subjected to biofilm growth and 
antibacterial procedures as described in subsections 2.3 and 2.4, respectively. After the 
completion of investigated antibacterial treatments and incubation in recharge medium (1 
hour, 37°C), biofilms were sonicated (Sonicator 3000, Misonix Incorporated; Farmingdale, NY, 
USA) to allow the efficient and reproducible detachment of bacterial biomass from the 
surface’s specimens. Aliquots (10 µL) of bacterial suspensions in recharge medium were then 
serially diluted (10-8). Finally, aliquots (10 µL) of each dilution produced (100 to 10-8) were 
then plated in triplicate on THY plates supplemented with streptomycin (800 µg/mL) that were 
incubated for 48 hours (37°C, anaerobic conditions). After the incubation period, viable colony 
counts (VCC, in CFU/mL) were visually determined, and calculated. The experiment to 
determine the antibacterial efficacy of treatments investigated was conducted as described 
in subsection 2.6 and was repeated four times. 
 
2.8 Morphological examination 
Scanning electron microscopy (JSM-5600LV; JEOL, Tokyo, Japan) was used to 
reveal the morphological and structural features observed on intact biofilms of S. mutans, and 
after NTAP treatments proposed. An additional set of specimens (n= 2/group) were subjected 
to the procedures described in subsections 2.1 and 2.3., respectively. Specimens were then 
fixed (2 hours, 4°C) with an aqueous solution of 2.5% glutaraldehyde (Sigma-Aldrich Corp; St 
Louis, MO, USA) before being subjected to sequential ethanol dehydration (50%, 60%, 70%, 
80%, 90%, and 100%; 10 min/step). After dehydration, specimens were mounted onto metal 
stubs and were sputter-coated with gold (Desk II, Denton Vacuum Inc.; Moorestown, NJ, USA) 
then observed at 500x and 6,000x magnification.  
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2.9 DNA extraction and polymerase chain reaction  
Immediately after the viable colony counts assay, aliquots (990 µL) of sonicated 
bacteria suspended in recharge medium were transferred to microcentrifuge tubes in 
preparation for DNA extraction and polymerase chain reaction (PCR). Microcentrifuge tubes 
were centrifuged (13,000 rpm, 4°C) for 2 minutes. Following, the supernatant was carefully 
aspirated to obtain a pellet of S. mutans that was exposed to the Wizard Genomic DNA 
Purification Kit (Promega, Madison, WI, USA) following the manufacturer’s instructions to 
allow for DNA extraction. The amount of DNA obtained was quantified photometrically 
(absorbance) at 260 nm (NanoDrop ND-1000 spectrophotometer, Thermofisher, USA). The 
amplification of the 16S rRNA was carried out using the primer listed in Table 2. For any given 
sample, PCR reactions contained Mastermix (12.5 µL; GoTaq Colorless Mastermix, Promega, 
USA), primer (0.75 µL, 10 nmol), template DNA (1 µL, corresponding to 280 ng) and sterile 
ultrapure water (10 µL). The four-step amplification program (step 1 - initial denaturation= 1 
cycle of 3 min at 94°C, step 2 - denaturation= 30 cycles of 30 s/each at 94°C, step 3 - annealing= 
1 cycle of 30 s at 56°C and step 4 -  extension= 1 cycle of 10 min at 72°C) was carried out in a 
Mastercycler® Gradient (Eppendorf, USA) PCR. To confirm successful amplification, 
electrophoresis procedures were conducted in agarose gel (0.9%) with added ethidium 
bromide (Sigma-Aldrich Corp; St Louis, MO, USA). Aliquots (15 µL) of PCR product samples 
were then loaded into separate wells using Loading Dye (Purple [6x], New England Biolabs, 
USA) and subjected to electrophoresis for 45 minutes (110 V). Four independent experiments 
were performed to determine the impact of antibacterial treatments on the DNA of intact 
biofilms of S. mutans. 
 
2.10 Statistical analysis 
Data for VCC were tested for normality and homogeneity using Shapiro-Wilks and 
Brown-Forsythe test respectively at a significance level of 95% (a = 0.05). Since VCC data was 
not normally distributed, experimental data was then corrected using the Box-Cox method 
(p = 0.6025). Corrected VCC data was then analyzed using one-way ANOVA and post hoc tests 
Dunnett and Tukey (a = 0.05). Additionally, for NTAP groups, ANOVA and polynomial 
regression were performed (a = 0.05). Metabolic activity data were tested for normality and 
homogeneity of variances using Shapiro-Wilks test (a= 0.05). Since data was not normally 
distributed (p < 0.05), the logistic model PROC GENMOD and the Wald test were used to 
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determine the existence of significant differences among mean values of relative metabolic 
differences. Statistical analyses were performed using the SPSS software (version 19.0; IBM; 
Armonk, NY, USA). For bioluminescence data, the calculation of the relative metabolic 
differences within each group were performed according to equation 1 [52] below: 
 !"#!"## = (%&'!(%&'")%&'"                                                                                                           eq. 
(1) 
 
, where Metdiff stands for relative metabolic difference, Meti stands for metabolic 
activity at baseline (BR0, BR2, BR4 and BR6) and Metf stands for metabolic activity after 
treatments (AR0, AR2, AR4 and AR6)  
 
3. Results 
The mean and standard deviation values of VCC are summarized on Table 3, where 
it is possible to observe that mean VCC values ranged from 0 CFU/mL (CHX) to 2.79 x 109 
CFU/mL (Col). It is also possible to observe that mean VCC values for the other experimental 
groups ranged from 6.23 x 105 CFU/mL (P150) to 2.31 x 108 CFU/mL (ARG). These results have 
indicated that CHX was the most effective antibacterial treatment investigated, thereby 
corroborating the present study’s rationale for the selection of 2% Chlorhexidine as a positive 
control group for the antibacterial effect. In addition, it is possible to observe that the 
polynomial regression (Figure 2) showed significance (p< 0.05) for the quadratic polynomial, 
where plasma displayed a time-dependent antibacterial effect against intact biofilms of S. 
mutans, and treatments could be rank ordered (ARG < P30 < P90 < P120 = P150) in terms of 
their efficacies. Moreover, experimental data indicate that application time (30-150 s) has an 
exponential relation to the reduction of bacterial viability and reaches its maximum 
antibacterial effect at 120 seconds. Figure 2 also suggests that antibacterial effects of plasma 
tend to reach a plateau around 100 s of treatment time.   
Table 4 and Figure 3 show the temporal evolution of relative D-Luciferin metabolic 
activity in intact biofilms of S. mutans as determined by the optimized HTS bioluminescence 
assay (BL) in terms of RLU values (median [min to max]). It is possible to observe in Table 4 
that median RLU values ranged from -0.83 (-0.95 to -0.54) in CHX (0 min) to 1.5835 (-0.15 to 
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2.92) in CON (0 min). The lowest D-Luciferin metabolic activity among experimental groups 
was observed in groups P90 (at 0 and 2 min) and P120 (at 0 min). It is also possible to observe 
that the factor “group” was a significant (p= 0.048) predictor of response (e.g., metabolic 
activity) and influenced RLU values. However, significant differences were not found (p> 0.05) 
for the factor “reading time” or the interaction between factors “group*reading time”, which 
indicates that cells within biofilms are still metabolically active immediately after the 
completion of the antibacterial treatments proposed. This observation suggest that plasma 
treatments may disrupt cells’ internal functions and cytoplasmic reactions, and cells may 
become non-viable over time (as seen with the VCC results). Figure 3 shows the relative 
metabolic differences of controls and experimental groups at each specific time point 
investigated (Metdiff 0, Metdiff 2, Metdiff 4 and Metdiff 6). The median values of relative 
metabolic activity in groups CHX, P90, P120 and P150 were observed to be negative, which 
indicates that these treatments were capable of reducing the biofilms’ metabolic activities. 
The median RLU values from groups CON, ARG and P30 were observed to be positive, and 
therefore, have indicated that biofilms in these groups had their metabolic status upregulated 
by the conditions and treatments investigated.  
Representative SEM images of S. mutans biofilms before and after the 
antibacterial treatments proposed are shown in Figures 4 (A-F) and 5 (A-H), where the effects 
of antibacterial treatments on the morphological and structural features of S. mutans biofilms 
are displayed. It is possible to observe in Figures 4A and 4D (CON) the typical structure and 
morphology of intact biofilms of S. mutans, which was an expected finding because specimens 
in this group did not receive any type of antibacterial treatment. In Figures 4B and 4E, it is 
possible to note that biofilms in CHX have not experienced any adverse impacts on their 
structure or morphology as a consequence of treatment. A different behavior was observed 
with the utilization of argon gas (ARG) as an antibacterial treatment (Figures 4C and 4F). In 
this instance, biofilms were observed to be dehydrated as a direct consequence of treatment. 
Despite this change, both VCC and BL results are in agreement that both the viability and 
metabolic status are minimally impacted by the treatment with argon gas. The results shown 
in Figure 5, indicate that all biofilms subjected to NTAP treatments (either 30 s, 90 s, 120 s or 
150s) were capable of inducing strong degradation of the structure and morphology of S. 
mutans biofilms that include localized damage to cell membranes, strong dehydration and 
even complete disruption of cells. With regard to their architectures, biofilms were observed 
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to be flattened as a consequence of NTAP treatments. As per what was observed in VCC 
values, the adverse effects of NTAP seemed to be time-dependent, where biofilms exposed 
to longer NTAP treatments (either 120 s or 150 s) displayed stronger adverse effects on their 
morphologies and structures. Despite these promising results, a few areas displaying biofilms 
with intact structures and morphologies were observed. This unexpected behavior could be a 
direct evidence that the manual sweeping technique used to apply NTAP treaments needs to 
be further refined or substituted by a computer-controlled system. Figure 6 shows the PCR 
results for all groups, where it is possible to observe that experimental groups treated with 
plasma displayed bands (at 1401 pb) that were less bright than those of the groups CON, CHX 
and ARG, thereby indicating the occurrence of NTAP-induced DNA damage. In corroboration 
with the VCC and SEM results, PCR results suggest that NTAP displayed a time-dependent 
effect, where longer NTAP treatments resulted in more DNA damage.  
 
4. Discussion  
This study showed that NTAP was effective against S. mutans biofilm. NTAP 
produced significant damage on the structure of investigated biofilms, reduced the viability of 
cells and their metabolic status, and promoted significant genetic damage. Thus, the first null 
hypothesis that plasma would not have any antibacterial effect against intact biofilms of S. 
mutans was then rejected.  
The rationale for the selection of resin composite discs as a substrate to grow 
biofilms was based on the fact that more than five hundred million resin composite 
restorations are place every year worldwide, [55] that these materials upregulate the 
aggregation and growth of oral bacterial [56] and by-products generated by hydrolysis and 
biodegradation, typically change the ecology of biofilms from a state of health into a disease-
associated state. [57] The rationale for the selection of 2% chlorhexidine as a positive control 
for antibacterial effect is based on the fact the chlorhexidine is a broad-spectrum agent with 
proven activity [53, 58, 59] against bacteria, some yeast and viruses.   
Previous studies have attributed NTAP’s antibacterial properties to a synergistic 
effect among RNS, ROS and UV-radiation. [32, 60, 61] It is believed that multiple interactions 
between free radicals (either RNS or ROS) and critical cellular components (membrane lipids, 
proteins, and DNA), [31, 45, 61, 62] results in lipid peroxidation and enzymatic activity 
disruption. The combination of these factors leads to the oxidation of several amino acids 
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from proteins and changes to the 3-dimensional structure of proteins. The cellular 
manifestation of these factors result in cells with compromised intracellular functions, that 
are not capable of maintaining their cytoplasmic pH levels, display unstable membranes and 
will eventually undergo inactivation due to the extravasation of intracellular contents. [28, 32] 
Other studies [63, 64] have indicated that highly reactive gas radicals react with the surfaces 
of cells and living organisms through an “etching” [65] mechanism. In this physical process, 
follow-up by-products desorb from surfaces and create perforations in the membranes of 
microorganisms, thereby allowing secondary reactive species to adversely impact intracellular 
components, enzymatic reactions and DNA.     
The present study has comprehensively demonstrated that NTAP treatments 
investigated were effective against 24-hour S. mutans biofilms. The results presented in Table 
3 suggest that antibacterial treatments were capable to adversely impact cells’ viability as 
denoted by VCC mean values that ranged from 6.23 x 105 CFU/mL (P150) to 2.31 x 108 CFU/mL 
(ARG), which were lower and significantly (p < 0.05) different when compared to the mean 
VCC values of the CON (2.79 x 109 CFU/mL). In addition, it is possible to observe that 
treatments associated with longer exposure times resulted in higher bacterial reductions. 
These findings reject the second null hypothesis that plasma does not display time-dependent 
antibacterial properties. The results reported in the present study are corroborated by 
previous investigations. Alkawareek et al. [64] while investigating potential cellular targets of 
NTAP, have demonstrated that planktonic cultures of Pseudomonas aeruginosa displayed 
reduced viability (1 log10) after 30 s and were completely eradicated after 2 min of treatment 
with NTAP. Li et al. [9] investigated the effect of plasma treatment times (either 3 or 12 
minutes) against biofilms of Enterococcus faecalis in root canals. The results reported have 
indicated that longer exposure times were associated with complete inactivation of biofilms. 
Despite these reports, the results of the present study (Figures 1 and 2) have shown that an 
antibacterial efficacy threshold is achieved after 100 seconds and further reductions in 
viability and metabolic status could not be observed.  
 These results can be explained by NTAP’s mechanism of action where, during 
the first few seconds of treatment, critically damaged components of biofilms (cells, EPS, 
proteins, etc.) are deposited onto biofilms’ outermost layers, thereby reducing NTAP’s ability 
to penetrate into deep regions of biofilms. Previous reports [30, 60, 64] have indicated that 
NTAP’s penetration depends on plasma composition, etching effectiveness and biofilm 
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characteristics (e.g., thickness, composition, etc.). According to those studies, [30, 60, 64] 
etching is more efficient against Gram-negative bacteria, and thicker biofilms typically present 
as a greater challenge for the penetration of plasma radicals. [20] The bacterial inactivation 
results (viability reduction= 0.99 log, Table 2) observed in ARG were lower and significantly 
different (p < 0.05) when compared to the groups treated with NTAP, thereby allowing to infer 
that non-ionized argon gas does not display any antibacterial properties against intact S. 
mutans biofilms. Similar results were also reported by other studies [66, 67] using argon 
plasma jet on biofilms and could be explained by the drying effect of the gas flow. [68] 
 The metabolic activity of intact S. mutans biofilms was measured before and 
after NTAP treatments using a novel bioluminescence assay recently reported. [50] This assay 
is capable of determining, in a real-time and high throughput manner, the metabolic status of 
intact biofilms by the emission of visible light (530 nm) constitutively produced by cells. 
According to previous studies [19, 49] the amount of light produced is strongly correlated to 
bacteria’s intracellular energy potential and the total amount of viable cells. [69] Figure 2 
shows the temporal evolution of metabolic activity for all groups investigated. This can be 
observed by significant reductions of metabolic activity was obtained in groups with longer 
treatment times (such as 90 s, 120 s and 150 s), which indicates that NTAP was able to 
immediately impact the metabolic status of intact S. mutans biofilms. Specimens in P30 
displayed mean values of Metdiff (in RLUs) that were similar to those of CON and ARG groups, 
thereby indicating that NTAP treatments with short exposure times were not able to 
drastically downregulate the metabolic status of intact biofilms. It has been previously 
demonstrated [7, 64, 68] that short NTAP treatment times results in concentrations of reactive 
species (either RNS or ROS) that are below the antibacterial threshold. This suboptimum 
process results in weak oxidative stresses that increase bacterial respiration and intracellular 
ATP levels, and therefore, can be used to explain the unexpected high levels of metabolic 
activity observed in P30.  
To investigate the hypothesis that NTAP treatments cause morphological and 
structural damage to biofilms and membranes of cells, an SEM analysis was performed. Figure 
5 shows that NTAP treatments were capable of modifing the 3-dimensional structure of S. 
mutans biofilms in a time-dependent manner, where the increase in exposure time resulted 
in structural damages that were more severe. These findings are in agreement with previous 
publications [63-65] and confirm the etching effects produced by NTAP treatments, thereby 
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rejecting the third null hypothesis that plasma does not display significant effects on the 
integrity of biofilms. Despite these promising results, Figure 5F shows the presence of small 
regions displaying intact biofilms. Such findings indicate that the manual sweeping application 
technique used during the delivery of NTAP is fundamentally important to ensure complete 
inactivation of biofilms.  
 Even though some studies have shown that NTAP has limited effect on DNA 
[45, 48, 61, 70, 71], the results shown on Figure 6 indicate that NTAP treatments were capable 
of damaging DNA in a time-dependent manner, where longer exposure times yielded more 
DNA damage. These results are in agreement with the findings from VCC, HTS and SEM 
experiments, thereby supporting the hypothesis that NTAP has a time-dependent 
antibacterial effect, and therefore, the fourth null hypothesis that plasma does not produce 
DNA damage on S. mutans biofilm was also rejected. A few studies have indicated that 
photons emitted by the NTAP could induce modifications on the nucleobases and thymine 
dimer formation, loss of DNA integrity [60, 72] mutations, [45, 72] thereby underscoring the 
need for further investigations on the effect of NTAP on persister cells.  
The results of the present study have demonstrated that NTAP could be used as 
an alternative method for decontamination of oral surfaces (both biotic and abiotic) prior to 
any treatment performed in the oral cavity. Among the numerous applications anticipated in 
dentistry, plasma could be used to disinfect cavity preparations, root canals [9, 73, 74] and 
implant surfaces [46] without the problems associated with traditional methods including 
antibiotic resistance, [25, 26] adversely impacts to adhesion procedures and longevity of 
polymer-based boned restorations. [12,13]. Additionally, based on NTAP’s unspecific and 
multi-target mechanism of action, it is very unlikely that resistant strains of bacteria will be 
developed from the recurrent utilization of NTAP. [7, 64]  
Even though the single-species biofilms evaluated in the present research are not 
relevant from the clinical standpoint, the cariogenic model used in the present study has been 
utilized for many years to screen the efficacy of numerous antibacterial approaches. [75] This 
study represents a proof of concept effort to determine NTAP’s antibacterial efficacy against 
intact biofilms of S. mutans grown against the surfaces of relevant polymer-based restorative 
dental biomaterials. Futures studies using in situ multi-species biofilms should be performed 
to confirm the results of the present study.  
 
 31 
5. Conclusions 
The results of the present study have clearly demonstrated the antibacterial 
efficacy of NTAP against intact S. mutans biofilms grown on the surfaces of relevant polymer-
based restorative materials. Treatment in P150 produced a reduction in bacterial viability of 
38.3%. Bioluminescence results have also indicated that NTAP treatments are capable of 
immediately reducing the metabolic activity of intact S. mutans biofilms. SEM observations 
revealed that NTAP treatments induce significant changes onto the structure of biofilms. PCR 
results have shown that NTAP produced DNA damage. Taken together, the findings of the 
present study indicate that NTAP could be a promising technique to reduce the intraoral 
bacterial load prior to any dental treatment. 
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Table1. Experimental groups 
Groups Treatment 
CON Growth control 
CHX 2% Chlorhexidine for 1 minute 
ARG Argon gas application for 150” 
P30 Plasma application for 30” 
P90 Plasma application for 90” 
P120 Plasma application for 120” 
P150 Plasma application for 150” 
 
Table 2. Oligonucleotides used in this study 
 
 
Table 3. Effect of plasma application on S.mutans biofilm (Log CFU/ml).  
Groups CFU log/ml 
Log 
reduction 
Killing 
rate 
ANOVA 
test 
Control 9.19 ± 0.45 Reference Reference A 
Plasma 30” 7.42 ± 0.48 1,77 19.2% B 
Plasma 90” 6.80 ± 0.25 2,39 26% C 
Plasma 120” 5.95 ± 0.12 3.24 35.25% D 
Plasma 150” 5.67 ± 0.4 3.52 38.3% D 
Argon gas 0 9.19 100% * 
Chlorhexidine 2% 8.20 ± 0.35  0.99 10.8% * 
Groups having similar letters are not significantly differences (p>0.05), * indicates 
significantly differences with all the groups. 
 
 
Primer name Sequence 5’-3’ Product size (bp) Source 
16SmutansF GGGTGAGTAACGCGTAGGTA 
1401 This study 
16SmutansR TGTTACGACTTCACCCCAAT 
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Table 4. Median (minimum and maximum) values of antibacterial efficacy of plasma 
treatment on S. mutans biofilm in terms of metabolic activity.  
Groups having similar letters are not significantly differences (p>0.05), * indicates 
significantly differences with all the groups, # indicates differences with P90, P120 and P150 
groups. 
 
 
 
 
 
Groups 
Time p-value 
Baseline 2 min 4 min 6 min  
Control 
1,58 
(-0,15 a 2.92) 
1,23 
(-0,18 a 3,61) 
1,15 
(-0,09 a 4,38) 
1,41 
(-0,46 a 4,28) 
C 
Plasma 30” 
1,13 
(0,07 a 6,47) 
0,94 
(-0,03 a 4,69) 
1,44 
(-0,05 a 3,51) 
1,37 
(-0,24 a 5,24) 
C 
Plasma 90” 
-0,39 
(-0,72 a 0,11) 
-0,41 
(-0,78 a 0,51) 
0,19 
(-0,78 a 0,39) 
-0,02 
(-0,84 a 0,67) 
A 
Plasma 120” 
-0,38 
(-0,57 a 0,08) 
-0,36 
(-0,65 a 0,11) 
-0,35 
(-0,58a -0,04) 
0,35 
(-0,65 a 0,26) 
A 
Plasma 150” 
-0,31 
(-0,80 a 0,43) 
-0,32 
(-0,68 a 0,31) 
-0,23 
(-0,68 a 0,11) 
-0,21 
(-0,68 a 0,55) 
B 
Argon gas 
0,87 
(-0,07 a 6,04) 
0,70 
(-0,31 a 5,85) 
0,83 
(-0,22 a 5,32) 
0,49 
(-0,22 a 3,35) 
# 
Chlorhexidine 
-0,83 
(-0,95 a -0,54) 
-0,72 
(-0,95 a -0,56) 
-0,66 
(-0,96 a -0,46) 
-0,69 
(-0,94 a -0,20) 
* 
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Figure. 1 Plasma sterilization effect on S. mutans biofilm in different plasma treatment times 
(in seconds). 
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Figure 2. Polynomial regression of the CFU of the S. mutans biofilm treated with NTAP for 
different times (in seconds). 
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Figure 3 Metabolic activity of the experimental treatments against S. mutans biofilms. 
 
Figure 4 Representative SEM micrographs of the S. mutans biofilm (24H, X600 and X3,000 
magnification), after the following treatments: G1(A, D); G2 (B, E); and G3 (C, F). Note that the 
biofilm in G3 more compact appearance (C, F) when compare with the G1(A, D), some ruptures 
(F) occurred on the biofilm in G3 due to effects of drying (Pointer). 
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Figure 5 Representative SEM micrographs of the S. mutans biofilm (24H, X500 and X3,000 
magnification), after NTAP treatment for G4 (A-B); G5 (C-D); G6 (E-F); and G7 (G-H). More 
damage on the biofilm structure was observed with the increase of the NTAP application. Note 
the presence of intact biofilm (white arrows) and some ruptures occurred on the biofilm due 
to effects of drying (Pointer) 
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Figure 6 Agarose gel electrophoresis showing genomic DNA of S. mutans and PCR-amplified 
products of experimental groups.  
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2.2. ARTIGO: Photodynamic inactivation of Streptococcus mutans by curcumin in 
combination with EDTA 
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Abstract 
Objective: The aim of this study was to test the efficacy of photodynamic inactivation (PDI) 
mediated by curcumin with EDTA against Streptococcus mutans in planktonic suspension 
using blue LED light. 
Methods: Antibacterial activity of curcumin and EDTA was evaluated by determination of their 
minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC). The 
fractional inhibitory concentration index (FICI) was used to estimate the synergistic effect of 
various combination ratios of curcumin and EDTA against S. mutans. Cultures of S. mutans 
were prepared to test (18 h, 37°C, 5% C02) the effect of curcumin-mediated PDI (50 µM and 
500 µM) with or without 0.4% EDTA and 40 seconds of light-activation with blue light. EDTA 
and each concentration of curcumin were also tested individually. Chlorhexidine (0.2%), was 
used as positive control. Planktonic suspensions were also analyzed by viable colony counts 
(VCC), confocal laser scanning microscopy (CLSM), transmission electron microscopy (TEM), 
and polymerase chain reaction (PCR). 
Results: The MIC values of curcumin and EDTA were 5 mM and 0.125% respectively. FICI 
showed a synergistic interaction between curcumin and EDTA. All the combinations with 
curcumin and blue LED light resulted in a complete inactivation of the S. mutans and CLSM 
confirm these results, TEM showed morphological changes produced by the PDI. No damage 
on the DNA structure was detected by the PCR.  
Significance: Curcumin-mediated PDI with EDTA using a blue light, shows a strong inhibitory 
effect against S. mutans in planktonic culture. Because of the unspecific target mechanism, it 
could be a promising technique for disinfection of dental tissues. 
 
Keywords: Photodynamic therapy, Curcumin, Disinfection, Photosensitizing agents, 
Streptococcus mutans, dental curing lights. 
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1. Introduction 
Streptococcus mutans is an endogenous bacteria of the oral cavity and is 
considered the primary causing agent of dental caries [1,2]. S. mutans has the ability to 
metabolize dietary carbohydrates to form acids, producing demineralization of dental hard 
tissues and developing extracellular polysaccharides by the action of their 
glucosyltransferases [3,4]. 
Clinically, management of dental caries is done by removing contaminated and 
demineralized dentin tissue[5] and bacterial remnants can lead to problems such as dental 
sensitivity, pulpal inflammation and secondary caries. To ensure complete dentinal 
disinfection, various antibacterial agents such as chlorhexidine have been indicated for use 
before placing a restoration, with good reported results [6]. However, the use of disinfecting 
agents has been associated with several problems, such as reduced bond strength to dentin 
[6,7], increased microleakage [8], marginal staining, and bacterial resistance [9,10]. Therefore, 
new therapies for decontamination of oral tissues without the adverse side effects of the 
traditional methods are of great interest in dentistry [11]. 
Photodynamic therapy (PDT) uses light to activate a photosensitizing agent in the 
presence of oxygen, resulting in the production of reactive oxygen species (ROS) to damage 
abnormal cells [12,13]. PDT has been successfully used in dermatology, oncology, gynecology, 
and urology [14]. Recent studies have shown that PDT can also inactivate bacteria in a process 
that has been called photodynamic inactivation (PDI) or photodynamic antimicrobial 
chemotherapy (PACT). Thus, the antimicrobial efficacy of PDI is based on liberation of ROS 
that cause damage to bacteria structures [15]. PDI does not have a specific mechanism of 
action or target structure, which reduces the possibility to develop bacterial resistance. At this 
moment, PDI has been used in dentistry to inactivate fungi and oral bacteria [16–18], 
sometimes combined with natural photosensitizers.  
Among the tested natural photosensitizers, curcumin has been used as anti-
inflammatory, anti-oxidant, and in the treatment of diabetes and different types of cancer 
[19]. Curcumin is a yellow, phenolic compound, extracted from Curcuma longa, widely used 
for seasoning [19,20],  that  has been recently used as a photosensitizing agent in PDI to 
inactivate bacteria including cariogenic oral bacteria [21]. Curcumin has a broad absorption 
range (range 300–500 nm), compatible with dental blue light curing units [15,16,22]. 
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The combined administration of antibacterial agents with potentializing or 
sensitizing agents has gained interest because it often leads to synergistic effects [23]. 
Ethylene-diamine-tetra-acetic acid (EDTA) has been used successfully to potentiate the 
efficacy of antibiotics [23–27] and photosensitizers [28].  EDTA can alter the permeability of 
the cell wall of bacteria by chelating calcium and magnesium ions [24,25]. These ions play a 
fundamental role in protecting the bacterial cell walls and their removal by EDTA might weak 
their structure facilitating the accessibility of other drugs [24,25]. The combination of 
curcumin with EDTA may enhance the passage of the photosensitizer through the cellular 
membrane, increasing its phototoxic effect on bacteria [28]. To our knowledge, only one study 
has evaluated the benefits produced by the combination of curcumin with EDTA against a 
dental biofilm [29]. 
In order to improve the knowledge about the potential disinfecting effect of the 
combination of curcumin with EDTA in dental tissues, the purpose of this study was to test the 
efficacy of curcumin-mediated PDI with EDTA against S. mutans in planktonic suspension using 
a blue light source. The null hypothesis tested were that (1) curcumin-EDTA would not have a 
synergic antibacterial effect against S. mutans; (2) curcumin-EDTA mediated PDI would not 
have an antibacterial effect against S. mutans in planktonic suspension; (3) curcumin-EDTA 
mediated PDI would not have a significant effect on the cellular integrity of S. mutans in 
planktonic suspension; and (4) curcumin-EDTA mediated PDI would not produce DNA damage 
against S. mutans in planktonic suspension. 
 
2. Materials and Methods 
2.1 Bacterial strain and growth conditions 
The experiments were performed using the S. mutans (Strain UA159) obtained 
from the laboratory of Microbiology and Immunology of the Piracicaba Dental School 
(University of Campinas, Piracicaba, Brazil). The bacterial culture was stored at -70°C in BHI 
medium (Difco Laboratories, Detroit, MI, USA) containing 20% (v/V) glycerol until needed. 
 
2.2 Photosensitizer 
Curcumin (Sigma-Aldrich, S. Louis, MO, USA) was used as a photosensitizing. A 
stock solution of curcumin (20 mM) was prepared in ethanol (Merck Millipore Corporation, 
Darmstadt, Germany). In the same way, a 5% stock solution of EDTA (USB Corporation, 
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Cleveland, OH, USA) was prepared in saline solution. Both solutions were filtered (0.22 µm 
pore size filter, Kasvi; São José do Pinhais, PR, Brazil), aliquoted and stored at -20°C in dark 
conditions until usage. The stock solutions were diluted in saline solution to obtain the final 
concentrations to be tested.  
 
2.3 Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) 
The antimicrobial activity of curcumin and EDTA was evaluated by determining 
their Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration 
(MBC). Cultures of S. mutans grown in THB culture medium supplemented with 0.3% yeast 
extract (THY) for 18 h at 37°C and 5% CO2. The cultures were measured for optical density at 
(OD600) ≥ 0.900 and adjusted to 0.06 with fresh THY medium. Curcumin was diluted from 20 
mM to 312.5 µM and EDTA was diluted from 2% to 0.015%. One hundred microliters of the 
adjusted inoculum were mixed with 100 µL of each curcumin or EDTA dilutions. Plates were 
incubated at 37°C and 5% CO2 for 24 h. After incubation, the row of wells with the lowest 
dilution showing no turbidity was defined as the MIC, to confirm the results a resazurin 
method was used [30]. A dilution of resazurin sodium salt (Sigma-Aldrich, S. Louis, MO, USA) 
(0.1%) was added to all wells (50 µL per well), and further incubated for 4 hours at 37°C and 
5% CO2 in dark conditions for the observation of color change.  
The MBC was determined by plating in triplicate 10 µL the content of the wells 
with concentrations 2 times higher than the MIC, before to the staining with resazurin. The 
MBC value was determined by plating on agar the lowest concentration of the extracts 
required to kill 99.9% of bacteria from the initial inoculum. Three series of independent 
experiments were performed for MIC and MBC. 
 
 
 
2.4 Fractional Inhibitory Concentration (FIC) and Fractional Inhibitory Concentration Index 
(FICI) 
The synergistic combinations between curcumin and EDTA were investigated 
using the fractional inhibitory concentration index (FICI) adapting the method described by 
Vuuren at al. [31]. The MIC values of curcumin and EDTA were used as starting stock 
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concentrations and were diluted in five different ratios (9:1, 7:3, 5:5, 3:7, 1:9). The MIC of each 
combination was obtained using the protocol described above. 
The following equations were used to calculate the FIC values for EDTA and 
curcumin.  
FIC (Curcumin) = 
MIC value of combined curcumin/EDTA 
MIC value of curcumin alone 
  
FIC (EDTA) = 
MIC value of combined curcumin/EDTA 
MIC value of EDTA alone 
  
Finally, the FICI of each combination were calculated based on the FIC values 
where FICI resulted by the sum of FIC(curcumin) and FIC(EDTA). The interaction was graded as: FICI 
< 1, synergy; FICI = 1, additive and FICI > 1, antagonistic [32]. Three series of independent 
experiments were performed. 
 
2.5 Light source 
A polywave light emitting diode curing unit (Bluephase G2; Ivoclar Vivadent, 
Schaan, Liechtenstein) was used in this study to excite the curcumin. This light-curing unit 
(LCU) has a 10-mm external diameter light guide with 9-mm internal active diameter. 
Information about the radiant emission spectrum, emittance and irradiance was obtained 
using a spectrophotometer (MSC 15W, SN 37560; Gigahertz-Optick, Amesbury, MA, USA) 
coupled to a software (MSC 15 Measurement Software v. 2019.1.0; Gigahertz-Optick, 
Amesbury, MA, USA). The LCU has a radiant emittance of 1,275 mW/cm2 at high power setting 
mode, providing a light emission ranking between 385 to 515 nm with two peak lights in 409 
and 454 nm. Characteristic emission spectrum is shown in Figure 1. The lamp was fixed in a 
clamp and the tip of the light guide was positioned perpendicular to the culture in the well 
with an area of 0.95 cm2 at 1 mm distance, for an irradiance of 839 mW/cm2.  Samples were 
irradiated twice for 20s cycle with an interval between cycles of 5 s, for a final radiant exposure 
of 33.5 J/cm2. The radiant exposure was calculated as the product of the irradiance multiplied 
by the total time of exposure (40 seconds). 
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2.6 Experimental groups 
The effect of combination of the EDTA (0.4%) and the curcumin (50 µM and 500 
µM) were tested with and without photoactivation on S. mutans planktonic culture. In the 
same way, the saline solution (negative control), EDTA, and each concentration of curcumin 
were also tested individually with and without photoactivation. Chlorhexidine gluconate (0.2% 
- Sigma-Aldrich, S. Louis, MO, USA) was used as positive antimicrobial control because it has 
been long recognized as potent bactericidal for chemical plaque control [33].  
 
2.7 Photoinactivation assay in planktonic culture 
Cultures of S. mutans were grown in THY culture medium (18h, 37°C and 5% CO2), 
measured for optical density at (OD600) ≥ 0.900 and used for inoculum. On the day of the 
experiment, the stock solution of curcumin was diluted in sterile saline to concentrations of 
1mM and 100 µM to give a final tested concentration of 500 µM and 50 µM. For EDTA, the 
stock solution was diluted in saline solution to concentration of 0.8%, chlorhexidine was 
diluted in sterile water to concentration of 0.4%, to obtain the final tested concentration of 
0.4% and 0.2%, respectively.  
Aliquots of 150 µL of S. mutans planktonic solution were individually transferred 
to separate wells of a 48-well plate (Kasvi; São José do Pinhais, PR, Brazil) to avoid light 
contamination and divided in 13 groups (n = 4).  Aliquots (150 µL) of the treatment solution 
were added to the wells containing the microorganism. For saline solution group, 150 µL of 
sterile saline solution was added. In the groups that received light treatment, the irradiation 
was applied after dark incubation for 3 min (pre-irradiation time). 
 
2.8 Viable colony counts (VCC) 
After treatment, 200 µL of the resulting bacterial suspension were serially diluted. 
Six, ten-fold serial dilutions were carried out for all the samples. Finally, aliquots (10 µL) of 
each dilution were plated in triplicate on THY plates. The colony-forming units (CFU) values 
were calculated after the plates were incubated (48 h, 37ºC, 5% C02). Three series of 
independent experiments were performed. 
 
2.9 Transmission electron microscopy (TEM) 
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A set of samples (n = 2) was prepared following the procedures described in the 
section 2.6 and 2.7. The samples of each group were pooled in 1.5 mL Eppendorf tubes. Then 
the tubes were centrifugated for 2 minutes at 11,000 rcf at 4°C and washed twice in saline 
solution. The samples were fixed in Karnovsky’s solution, with post-fixation in 1% osmium 
tetroxide in 0.2 M Sorensen’s phosphate buffer. Samples were washed with the same buffer, 
dehydrated in a graded acetone series and embedded in Spurr’s resin. Thin sections of the 
specimens were stained with uranyl acetate. Finally, the grids were exanimated by TEM (JEM-
1400, JEOL, Tokyo, Japan). 
 
2.10 Live and dead cell assay  
A set of samples (n = 2) were prepared following the procedures described in the 
section 2.6 and 2.7. The cultures were stained using a live/dead BacLight Bacterial Viability Kit 
(Life technologies, Carlsbad, CA, USA).  Live/dead stain was prepared by diluting 1 μL of SYTO9 
(excitation (λ) = 485 nm, emission = 498 nm) and 1 μL of propidium iodide (excitation (λ) = 535 
nm, emission = 617 nm) in 1 mL of distilled water. Tubes containing the treated culture were 
centrifugated for 1 minute at 5,000 rcf, resuspended with 100 µL of staining solution and 
stored at 37°C for 30 minutes. Then, the bacteria cultures were analyzed by confocal laser 
scanning microscopy (CLSM). A series of images were obtained in the Z section (0,5 µm) using 
a confocal laser scanning microscope (TCS SP5 MP, Leica Microsystems GmbH, Wetzlar, 
Germany).  
 
2.11 Genomic DNA extraction and Polymerase chain reaction (PCR) 
The genomic DNA damage was evaluated by the amplification of conserved 
bacterial regions using the 16S rRNA. The PCR was performed using the primers listed on Table 
1. A new set of samples (n = 2) was prepared following the procedures described in the section 
2.6 and 2.7. The samples of each group were pooled in 1,5 mL Eppendorf tubes to obtain a 
higher number of bacteria. Then the tubes were centrifugated for 2 minutes at 11,000 rcf and 
4°C. The supernatant was carefully discarded to obtain the pellet, the genomic DNA was then 
extracted using the phenol-chloroform extraction method. The DNA obtained was quantified 
by measuring the absorbance at 260 nm. (NanoDrop ND-2000 spectrophotometer – 
Thermofisher, Waltham, MA, USA). All the PCR reactions (25 µL) were performed with a mix 
containing 2.5 µL of 1X buffer solution (10X Reaction Buffer Taq Polymerase; INVITROGEN-Life 
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Technologies Brazil; Sao Paulo, SP, Brazil), 1.25 µL of MgCl2 (50 mM), 0.5 µL of dNTPs (10 mM; 
DNA Polymerization Mix; INVITROGEN-Life Technologies Brazil; Sao Paulo, SP, Brazil), 0.125 
µL of Taq DNA Polymerase (5 U/µL; INVITROGEN- Technologies Brazil; Sao Paulo, SP, Brazil), 
0.75 µL of each primer (10 nmol), 1 µL of genomic DNA as template and 18.125 µL of sterile 
water. Amplification program was performed with a Verity Thermal Cycler (Applied 
Biosystems; Foster City, CA, USA), with an initial denaturation at 94°C for 3 min, followed by 
30 cycles amplification consisting of denaturalization at 95°C for 30 seconds, annealing at 56°C 
for 30 seconds, extension at 72°C for 90 seconds and  final extension at 72°C for 10 minutes.   
Electrophoresis was carried out in 0.9% agarose gel, with ethidium bromide 
(Sigma-Aldrich Corp, St Louis, MO, USA) staining at 110 V for 45 minutes. PCR product samples 
(15 µL) were loaded for each well, with Gel Loading Dye, Purple (6x) (New England Biolabs, 
Ipswich, MA, USA). Three series of independent experiments were performed. 
 
2.12 Statistical analysis 
Viable colony counts data were tested for normality and homogeneity of variances 
using Shapiro-Wilk and Levene’s Test (a = 0.05), which indicated that data set was not 
normally distributed (p < 0.05). Data were then corrected by using the Box-Cox method 
(**0.01) and were analyzed by using One-Way ANOVA and Dunnett’s post hoc (a = 0.05), 
comparing all the groups with chlorhexidine (positive control). Additionally, Two-Way ANOVA 
(Treatment*Photoactivation) and Tukey’s post hoc (a = 0.05) was performed to compare all 
the groups with and without photoactivation, excluding the chlorhexidine group. Statistical 
analyses were performed by using SAS software for windows (Version 9.3; SAS Institute, NC, 
USA).  
 
3 Results 
The results of the inhibitory effect on S. mutans growth by curcumin and EDTA 
revealed a dose dependent effect. The MIC for curcumin and EDTA were identified at 
concentrations of 5 mM and 0.125% (1250 µg/mL), respectively.  In addition to the inhibitory 
effect, the MBC values were investigated, and the same values were obtained for the MBC in 
both cases. 
The mean MIC values of the combination profiles of curcumin and EDTA were 
plotted on an isobologram (Figure 2) using Microsoft Excelâ software. The isobologram 
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provides a graphical representation of the interaction between each combination´s MICs with 
the independent MICs. In the case of curcumin and EDTA a synergistic effect was observed for 
all the combinations and the synergy was highest for the ratio 9:1. The FICI values of the tested 
combinations are presented in Table 2. A synergistic effect (<1) of FICI=0.5 was obtained for 
all the combinations profiles, except for the 9:1 ratio that showed the greatest synergistic 
effect (FICI=0.25). 
Means and standard deviations of the VCC are summarized on table 3. One-Way 
ANOVA showed significant differences [F(12,143)=84.97; p<0.0001],between the groups and 
chlorhexidine group. Photoactivated curcumin groups presented no significant difference 
regardless the curcumin concentration or the EDTA combination when compared with 
chlorhexidine group (table 3). Two-Way ANOVA showed significant for the factors “treatment” 
[F(5,132)=42.05; p<0.0001],  “photoactivation” [F(5,132)=434.01; p<0.0001], and the 
interaction “treatment*photoactivation” [F(5,132)=34.46; p<0.0001]. No significant 
differences were found between the groups without photoactivation (table 3).  
Live/Dead analysis was performed by CLSM on the S. mutans planktonic culture 
after PDI treatments and the representative images of the experimental groups are shown in 
Figures 3 and 4. Qualitative confocal analysis clearly demonstrated that PDI using curcumin 
was effective. All the photoactivated curcumin treated samples showed higher number of 
non-viable bacteria than the saline solution and EDTA groups, regardless the concentration or 
the combination with EDTA. The treatment with 0.2% chlorhexidine resulted in dead bacteria 
as well (Figure 4). For the groups treated with Curcumin combined or not with EDTA, and 
without photoactivation, a greater number of non-viable bacteria were observed when 
compared with the saline solution and EDTA groups. (Figure 3 and Figure 4) 
Visualization of the ultrastructure morphology of curcumin-treated S. mutans was 
performed by TEM and the representative microscopic images are shown in Figures 5, 6 and 
7. Saline solution and EDTA groups treated with blue light or not exhibited regular bacterial 
morphology, without visible changes on their structures (Figures. 5A – 5D). Figures 5E and 5F 
show that 50 µM curcumin-treated S. mutans presented morphological changes, including 
vacuoles formation and irregularities on the cell membrane, that increased with light 
irradiation. Also, precipitation of curcumin particles was found in the medium. The treatment 
with 500 µM curcumin and light exposure (Figure 6A and Figure 6B) also produced vacuoles 
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formation; nevertheless, alterations on the cell membrane were less evident, and 
precipitation of curcumin particles increased. 
The combination of curcumin and EDTA produced different results depending on 
the curcumin concentration and light exposure. For the non-irradiated groups, alterations on 
the cells were less evident. For the blue light-treated groups, the combination of 50 µM 
curcumin and EDTA produced vacuoles formation, deformation and rupture on cell 
membrane. For the 500 µM curcumin and EDTA group, vacuoles formation was reduced, and 
a greater precipitation of curcumin particles was observed. Notoriously, all the groups treated 
with 500 µM curcumin presented curcumin aggregates on the cell membrane (Figure 7B). 
Finally, the culture treated with 0.2% chlorhexidine showed bacteria with alterations in the 
wall membrane. Chlorhexidine did not disrupt the bacteria and the integrity of the bacteria 
remained intact. 
The DNA damage was also investigated by performing PCR and the Figure 8 
represents the PCR-amplified products of each experimental groups. PCR results showed no 
noticeable differences between the experimental groups. Thus, the curcumin-mediated 
photodynamic inactivation with or without EDTA against S. mutans did not result in DNA 
damage. 
 
4 Discussion 
This study clearly demonstrates the efficacy of curcumin-mediated PDI with or 
without EDTA using a blue light source on the planktonic culture of S. mutans. In this study, 
special attention was given to the protocol of the light exposure by the blue light device during 
the photoactivation. This optimization allowed to reduce significantly the application time, 
compared with other studies, reaching clinically acceptable application times. Moreover, the 
combination of curcumin and EDTA was effective and produced a synergistic effect 
potentiating the treatment efficacy.  
The MIC and MBC values for curcumin and EDTA showed a weaker antibacterial 
activity against S. mutans. The MIC for curcumin in previous study ranked between 125 µM to 
375µM against S. mutans [34–36], those values are lower to the MIC obtained in this study.  
Different methodologies and experimental designs used by those investigations could explain 
the variations of the results. On the other hand, the results showed that EDTA has bactericide 
activity against S. mutans, which seems new information to the field. Previous studies on other 
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strains have showed antibacterial efficacy of the EDTA specially against Gram negative 
bacteria, that may be attributed to its capability to sequester divalent ions of the bacterial 
membrane [23,37,38].   
The results showed that the combination of curcumin/EDTA was synergistic 
against S. mutans. The synergy was identified for all the tested ratios, with a higher effect for 
the 9:1 curcumin/EDTA ratio (Table 2 and Figure 2). These results suggest that EDTA facilitates 
the access of curcumin trough the bacterial membrane. Combinations of EDTA with antibiotics 
and photosensitizers have already been tested, and synergistic interactions have been 
reported [23,27,38]. As a Gram-positive bacterium, S. mutans is more resistant to the EDTA 
due to the composition on its membrane. However, the potentiation of antimicrobial activity 
of curcumin by the EDTA against S. mutans, obtained in this study could be explained by the 
chelation of the magnesium and manganese cations. These cations are essentials for the initial 
biosynthesis of the bacterial peptidoglycans [39]. These findings reject the first null hypothesis 
that curcumin/EDTA combination would not have a synergic antibacterial effect.  
The results confirm that curcumin (50 µM or 500 µM) in combination with blue 
light is effective to completely inactivate S. mutans in planktonic suspension (Table 3). All the 
curcumin concentration regardless the combination with EDTA resulted in complete 
eradication of S. mutans.  The results of viable colony counts showed no antibacterial effect 
when curcumin was used in absence of blue light confirming its mechanism of action based 
on the ROS production. Previous studies have demonstrated the antimicrobial activity of PDI 
with curcumin [21,40,41]. However, a large variation on the protocols of application was 
observed, even when the same photosensitizer and light source were employed, a great 
diversity on the irradiation protocols (time, power, and irradiance) and in the photosensitizer 
concentration were found [12,42] and comparison between results is difficult and not 
recommended. Therefore, the second hypothesis stating that curcumin-EDTA mediated PDI 
would not have an antibacterial effect was rejected. 
The light source and the energy delivered are factors that affect the performance 
of PDI. Much attention was given to these two aspects to improve the performance of PDI 
with curcumin. Since curcumin mainly absorbs light within the wavelength range of 400 and 
500 nm [16,41], a polywave LED blue light unit with two peak lights (409 and 456 nm) was 
selected. The use of a polywave LED unit produce a greater coverture to the spectral 
absorption of the curcumin, allowing more efficient activation of the photosensitizer. To 
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improve the amount of energy delivered by the light unit a careful review of other studies 
using blue light was performed. The light energy used by other studies was between 9 and 
200 J/cm2 [16] with times up to 32 minutes [43]. Based on this and as explained above, the 
proposed protocol delivered 33.5 J/cm2 of energy at 1 mm distance. The introduction of these 
improvements allowed reducing the photoactivation time to 40 seconds, that is a clinically 
reasonable, commonly used time. Therefore, the optimization of the light curing source and 
energy delivered allowed to use the dental curing light for PDI, without the need to invest in 
new equipment. 
The effectiveness of curcumin-mediated PDI was confirmed by the Live/Dead 
assay. However, in the non-photoactivated, curcumin treated groups, with or without EDTA, 
a significant increase on the non-viable cells was observed that seemingly contradicts the 
results obtained for VCC assay. Propidium iodide (PI) is a red fluorescent agent that can be 
used to stain cells and nucleic acids. PI can pass through the membrane only when it has been 
permeabilized or suffered some injure [44]. Some studies have reported that bacteria 
identified as non-viable may exhibit an intermediate state as a result of environmental stress 
[45]. In our study, intermediate state can be the result of an increase in the membrane 
permeability mediated by curcumin, allowing the progressive penetration of the PI. Previous 
studies report that cells with compromised integrity can recover their viability when returned 
to a favorable environment [45,46]. Based on the VCC results, the cells identified as non-viable 
in the groups treated with curcumin, were able to recover their viability.  
The TEM images (Figures 5 and 6) clearly demonstrate the alterations in the 
bacterial structure after curcumin-mediated PDI treated with EDTA, however the effects on 
the S. mutans ultrastructure were not the same for all groups. The EDTA- treated groups, 
exhibit evident damage of the bacterial structure, that was even more significant for the group 
treated with 50 µM curcumin, 0.4% EDTA, and irradiated with blue light. Interestingly, the use 
of 500 µM curcumin did not result in the same cellular damage. Thus, the third hypothesis 
that states that curcumin-EDTA mediated PDI would not have a significant effect on the 
cellular integrity of S. mutans in planktonic suspension was partially rejected. Based on the 
results, the damage on the S. mutans is dependent on the concentration and the combination 
or not with EDTA. As reported previously, the effectivity of curcumin decreased at higher 
concentrations, while no accumulative effect was found[41]. Similar results were found by Lee 
et al., which observed 100% bacterial inactivation with concentrations between 10 ng/mL and 
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103 ng/mL but reported only 10% reduction with a concentration of 104 ng/mL. According to 
the authors, it could be a result of incomplete dissolution of curcumin in the medium (Figure 
7), impeding the interaction with light [40]. In this study, the use 50 µM curcumin and blue 
light produced a strong effect on the bacterial structure. It was observed formations of 
vacuoles inside bacteria (Figure 6) and the effect was enhanced with EDTA treatment (Figure 
6). On the contrary, the use of 500 µM curcumin was less effective and resulted in less vacuole 
formation and no alteration in the cell membrane (Figure 6). Additionally, in the groups 
treated with 500 µM curcumin, TEM images revealed the presence of curcumin aggregates on 
the outside of the cell wall (Figure 7B). Probably, the formation of curcumin aggregates might 
reduce the formation of oxygen radicals during photoactivation and the effects of curcumin. 
It must also been taken into account that curcumin has extremely low bioavailability and 
water solubility [20]. TEM and CLSM images the confirm the formation of curcumin 
aggregations, they were more evident in the groups treated with 500 µM curcumin (Figures 3 
to 6).  
The synergism between EDTA and other photosensitizers has been reported 
previously; however, is not completely clear how this synergic effect works. In this study, it 
was considered that the synergistic effect resulted from differences in cellular penetration, 
for the chelation of some ions as explained above. TEM imagens showed that presence of a 
high number of curcumin particles in the cytoplasm was more noticeable in the EDTA treated 
groups (Figure 6). The results imply that EDTA can alter the permeability of the cell wall, 
allowing the more efficient penetration of curcumin on the bacteria structure [47]. 
The effect of curcumin-mediated PDI with EDTA on the genomic DNA was also 
evaluated by PCR. The results showed that the proposed treatment did not result in significant 
DNA damage (Figure 8). Thus, the fourth hypothesis stating that curcumin-EDTA mediated 
PDT would not produce DNA damage against S. mutans in planktonic suspension was 
accepted. As stated earlier, the mechanism of action on the PDI is based on ROS generation 
where the singlet oxygen is considered the more important [16,48]. Singlet oxygen is capable 
to penetrate into the cell, degrade the membrane cell, and the nucleic acids [49]. When 
compared with other photosensitizers curcumin has a lower quantum yield of radicals [13]. In 
general, photosensitizers irradiated by blue light sources produce lower amount of ROS than 
other red light activated photosensitizers[41]. The lower quantum yield of radical could 
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explain the why curcumin did not cause damage on the DNA structure on S. mutans. However, 
a recent study show that curcumin can induce DNA damage on Candida albicans [50].  
This study confirms that damage of the membrane is a key mechanism of curcumin 
action, without damaging the DNA structure, although the radical generation promoted by 
the ROS without an specific target structure or metabolic pathway, reduces significantly the 
risk to develop bacterial resistance [49,51]. Regarding the experimental design, several studies 
have shown that the S. mutans is susceptible to the action of the PDI, and therefore the 
evaluation of the novel treatment on a planktonic culture of S. mutans is the first step to 
establish a protocol, despite methodological limitations. However, dental caries results from 
the formation of a biofilm, that tends to minimize the effectiveness of PDI, because the biofilm 
structure significantly reduces the penetrability of curcumin into the bacteria,  and for that 
reason further studies using S. mutans biofilm are required to confirm the effectiveness of PDI 
with the curcumin-EDTA combination. 
 
5 Conclusions 
The combination of curcumin/EDTA was synergistic against S. mutans. Blue light 
activated, curcumin-mediated, PDI with or without EDTA, was effective to inactivate S. mutans 
in planktonic suspension. Based on the TEM observation, the combination of low 
concentration (50 µM) curcumin and EDTA produces significant alterations on the bacteria 
ultrastructure. However, no damage of the genomic DNA was observed. Our results showed 
that curcumin-mediated PDI with EDTA could be a promising technique to reduce S. mutans 
viability, without the problems of the disinfecting agents. 
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Table1. Oligonucleotides used in this study 
 
 
 
Table 2. FICI of curcumin in combination with EDTA where FICI < 1, synergy (S); FICI=1, additive 
(A) and FICI > 1, antagonistic (AT). 
 
FICI: Curcumin + EDTA 
1:9 3:7 5:5 7:3 9:1 
S. mutans 0.5 (S) 0.5 (S) 0.5 (S) 0.5 (S) 0.25 (S) 
 
 
 
 
 
 
 
 
 
 
 
Primer name Sequence 5’-3’ Product size 
(bp) 
Aneling 
temperature 
Source 
16SmutansF GGGTGAGTAACGCGTAGGTA 
1401 56°C This study 
16SmutansR TGTTACGACTTCACCCCAAT 
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Table 3. Antibacterial effect of the different treatments on S. mutans planktonic culture (Log 
CFU/mL).  
 
 
 
 
 
 
 
Means followed by similar letters (upper case letters compare treatments for the same light 
condition, while lower case letters compare light conditions for the same treatment) indicate 
no significant difference by two-way ANOVA and post-hoc Tukey’s test (p > 0.05).  * Indicates 
difference with chlorhexidine group by one-way ANOVA and post-hoc Dunnett’s test (p > 
0.05).   
 
 
 
 
 
 
 
 
 
 
Groups Non-Photoactivated Photoactivated 
Saline solution 8.21 ± 0.1 Aa* 8.16 ± 0.13 Aa* 
0.4% EDTA 8.22 ± 0.1 Aa* 8.18 ± 0.1 Aa* 
50 µM Curcumin  8.19 ± 0.09 Aa* 0 Bb 
500 µM Curcumin  8.22 ± 0.13 Aa* 0 Bb 
50 µM Curcumin +EDTA 8.20 ± 0.08 Aa* 0 Bb 
500 µM Curcumin +EDTA 8.16 ± 0.06 Aa* 0 Bb 
0.2% Chlorhexidine 0   
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Figure 1. (A) Emission spectrum from of the polywave Bluephase Style LCU with peaks on 409 
nm and 456 nm and (B) absorption spectrum of curcumin dye. 
 
 
 
 
 
 
 
Figure 2. Isobologram showing the synergistic effect of curcumin with EDTA against S. mutans 
(UA159). The MICs of curcumin and EDTA are represented as a straight line, the MICs of each 
curcumin:EDTA combination are represented by points. Sinergy, additivity, or antagonism 
interaction is indicated when the point is located below, on, or above the straight line, 
respectively. A synergistic effect was observed for all the curcumin:EDTA combinations, the 
synergy was best noted for the ratio 9:1. 
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Figure 3. Representatives CLSM images of the S. mutans planktonic culture (X65 
magnification), showing the non-photoactivated (left side) and photoactivated (right side) 
effects, after the following treatments: Saline solution (A-B); EDTA (C-D) and 0.2% 
chlorhexidine (E). Viable cells are green due to SYTO 9 staining and cells with damaged 
membranes are red due to propidium iodide staining.  
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Figure 4. Representatives confocal laser scanning microscopy images of the S. mutans 
planktonic culture (X65 magnification), showing the non-photoactivated (left side) and 
photoactivated (right side) effects, after the following treatments: 50 µM curcumin (A-B); 500 
µM curcumin  (C-D); 50 µM curcumin + EDTA (E-F) and 500 µM curcumin + EDTA (G-H). Viable 
cells are green due to SYTO 9 staining and cells with damaged membranes are red due to 
propidium iodide staining.  
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Figure 5. Representative TEM micrographs of the S. mutans ultrastructure (X40K 
magnification), showing the non-photoactivated (left side) and photoactivated (right side) 
effects, after the following treatments: Saline solution (A-B); EDTA (C-D) and 0.2% 
chlorhexidine (E).  
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Figure 6. Representative TEM micrographs of the S. mutans ultrastructure (X40000 
magnification), showing the non-photoactivated (left side) and photoactivated (right side) 
effects, after the following treatments: 50µM curcumin (A-B); 500µM curcumin (C-D); 50 µM 
curcumin + 0.4% EDTA (E-F) and 500 µM curcumin + 0.4% EDTA (G-H). Note the presence of 
vacuoles on the groups treated with curcumin and light (Pointer). Open arrow indicates 
curcumin particles, black arrows indicate alterations on the form of the cellular membrane 
and the asterisks indicate membrane rupture. 
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Figure 7. Representative TEM micrograph of Curcumin aggregates observed at the 500 µM 
curcumin solution (A); and the S. mutans ultrastructure (X80000 magnification), showing the 
presence of curcumin aggregates on the surface of the membrane on the groups treated with 
curcumin 500 µM (B, Pointer). 
 
 
Figure 8. PCR gel electrophoresis showing 16S rRNA gene bands (at 1401 bp) of the 
experimental groups. Line L: Gel Loading Dye, Purple (6x), DNA leader. Abbreviations: bp (base 
pairs), L (leader), 1 (Saline solution), 2 (0.2% Chlorhexidine), 3 (Saline solution + 
Photoactivation), 4 (0.4% EDTA), 5 (50 µM curcumin), 6 (50 µM curcumin  + Photoactivation), 
7 (0.4% EDTA + Photoactivation), 8 (50 µM curcumin + 0.4% EDTA), 9 (50 µM curcumin  + 0.4% 
EDTA + Photoactivation), 10 (500 µM curcumin), 11 (500 µM curcumin + Photoactivation), 12 
(500 µM curcumin + 0.4% EDTA), and 13 (500 µM curcumin + 0.4% EDTA + Photoactivation)  
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3. DISCUSSÃO 
A aplicação de plasma frio em pressão atmosférica e a inativação fotodinâmica 
mediada por curcumina e EDTA ativada com uma fonte de luz LED azul se mostraram efetivos 
na inativação de S. mutans organizados em biofilme e cultura planctónica respetivamente e 
produziram alterações estruturais nas bactérias. Entretanto, somente o NTAP foi capaz de 
gerar alterações na estrutura do DNA bacteriano. 
A capacidade antibacteriana de ambos tratamentos é o resultado de um complexo 
processo que inclui a combinação de diferentes efeitos antibacterianos, baseados na 
produção de ROS que produzem um severo estresse oxidativo o que finalmente resulta na 
desintegração bacteriana (Mai-Prochnow et al., 2014). Devido ao mecanismo de ação 
inespecífico e de múltiplos alvos mostrado por ambas terapias, é improvável observar o 
aparecimento de cepas de bactérias resistentes resultantes da aplicação do plasma ou PDI. 
Como resultado do tratamento com o plasma um severo dano na estrutura do 
DNA foi confirmado pela PCR. Como afirmado anteriormente, as ROS e RNS interagem com a 
membrana bacteriana comprometendo sua integridade, vertendo as estruturas intracelulares 
para o meio, fazendo com que o DNA seja degradado pelas ROS (Kelly-Wintenberg et al., 1998; 
Xiong et al., 2011; Pei et al., 2012; J.-W. Lackmann et al., 2013; Privat-Maldonado et al., 2016). 
De forma contrária, a PDI mediada pela combinação cúrcuma/EDTA não ocasionou em danos 
no DNA. Embora as ROS não foram medidas neste estudo, provavelmente a quantidade e 
qualidade produzidas pela PDI sejam muito menores do que as produzidas pelo NTAP. Além 
disso, a cúrcuma possui uma baixa reatividade quando comparada a outros 
fotosenssibilizadores (Liu et al., 2015). 
Este estudo mostrou que um elemento fundamental para o uso da PDI é a 
configuração da fonte de luz, assim, muita atenção foi dada para este elemento e os 
resultados mostraram que uma completa inativação do S. mutans em cultura planctónica 
pode ser atingida com uma aplicação de 40 s utilizando uma fonte de luz azul de uso clínico. 
Neste aspecto, a PDI apresenta-se como uma opção mais econômica e simples de usar na 
prática clínica do que o plasma, pois não envolve a aquisição de novos equipamentos por parte 
do clínico. 
Em relação aos métodos utilizados nesta pesquisa para avaliar a viabilidade 
bacteriana, o método de bioluminescência mostrou-se mais confiável quando comparado 
com o teste LIVE/DEAD com microscopia confocal. O iodeto de propídeo é um agente 
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fluorescente que pode atravessar a membrana celular quando ela está permeabilizada ou 
quando sofreu alguma injúria (Tyagi et al., 2015). Deste modo, bactérias identificadas como 
não viáveis podem se encontrar em um estado intermediário como resultado do estresse 
ambiental (Van Impe et al., 2018). Assim, neste ensaio, bactérias em estados intermediários 
aparecem como não viáveis, o que reduz a sensibilidade do teste. No ensaio de 
bioluminescência, após a aplicação do tratamento, as bactérias são incubadas por uma hora 
em glucose a 1%, o que permite a recuperação de bactérias que sofreram algum dano e 
possibilita a obtenção de uma leitura muito mais precisa da viabilidade celular. 
Com relação às limitações de cada um dos tratamentos avaliados nesta pesquisa. 
O mecanismo de ação do plasma apresentou um “efeito autolimitante”, como resultado da 
rápida destruição das bactérias, um acúmulo dos restos bacterianos é formado sobre a 
superfície do biofilme, reduzindo rapidamente a efetividade do tratamento (Lerouge et al., 
2000; Ermolaeva et al., 2011). Este acúmulo de restos celulares, atua como meio de barreira 
física para as camadas mais internas do biofilme (Sladek et al., 2007), impedindo que sejam 
atingidas pelo plasma (Abramzon et al., 2006; Joaquin et al., 2009). As imagens de MEV 
mostraram a presença de bactérias intactas inclusive após 150s de aplicação de plasma. O 
ensaio de bioluminescência evidenciou uma atividade metabólica reduzida nos grupos com 
maior tempo de tratamento com plasma, e baseado nos resultados da CFU, as bactérias que 
não foram afetadas pelo plasma mantém a sua capacidade de reprodução.  
Para o tratamento de PDI mediada por curcumina/EDTA a principal limitação da 
terapia é a baixa solubilidade da cúrcuma em água (Tsuda, 2018), o que poderia limitar a sua 
efetividade. As imagens de TEM mostraram uma grande precipitação de partículas nos grupos 
tratados com uma concentração de 500 µM de curcumina. Estas partículas entram em contato 
com a membrana citoplasmática da bactéria, mas aparentemente não reagem 
adequadamente quando submetidas à irradiação azul.  
Diversos estudos têm mostrado que é muito mais difícil inativar bactérias que se 
encontram formando biofilmes do que quando em estado planctónico (Mai-Prochnow et al., 
2014; de Oliveira et al., 2016). Assim, novas pesquisas sobre biofilme que avaliem a 
efetividade da PDI mediada pela combinação curcumina/EDTA devem ser realizadas para 
poder fazer uma comparação mais precisa da efetividade desta terapia com outras já 
existentes.  
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Finalmente, ambos artigos apresentados podem ser enquadrados como estudos 
de prova de conceito, pois mostram que estas duas estratégias podem ser utilizadas 
efetivamente na inativação bacteriana. Porém, outros estudos devem ser realizados com a 
finalidade de determinar sua verdadeira aplicabilidade clínica. Na cavidade bucal as bactérias 
geralmente se encontram formando biofilmes multiespécies, enquanto as apresentações em 
forma planctônica ou em biofilmes monoespécies são improváveis. Adicionalmente, outros 
fatores devem ser levados em consideração, como a umidade, distância e tempo de aplicação, 
efetividade a longo prazo e a presença de possíveis efeitos adversos resultantes da aplicação 
destas terapias. 
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4. CONCLUSÃO 
Baseado nos resultados do presente trabalho in vitro, pode-se concluir que tanto 
a aplicação do plasma frio de argônio em pressão atmosférica como a PDI mediada pela 
combinação curcumina/EDTA podem reduzir significativamente a viabilidade do S. mutans por 
meio das ROS geradas por ambos tratamentos. Deste modo, ambos tratamentos se 
apresentam como técnicas promissoras para reduzir a viabilidade de S. mutans. 
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